Skip to main content

Thyroid Eye Disease News

Related terms: TED

Thresholds for Preop Serum Calcitonin Predict Lymph Node Metastasis in Thyroid Cancer

WEDNESDAY, July 2, 2025 – Updated threshold values of preoperative serum calcitonin predict different extents of lymph node metastasis (LNM) in patients with medullary thyroid cancer (MTC),...

Potential Genetic Link ID'd Between Thyroid Disease, Alopecia Areata

WEDNESDAY, Oct. 30, 2024 – There seems to be a significant association between hypothyroidism, Hashimoto thyroiditis, subacute thyroiditis, and alopecia areata (AA), according to a study published...

Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for Tepezza (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration

DUBLIN--(BUSINESS WIRE)--Apr. 14, 2023-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the Indications and Usage...

FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)

DUBLIN--(BUSINESS WIRE)--Jan. 21, 2020-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved Tepezza (teprotumumab-trbw) for the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Thyroid Disease

Related drug support groups

Tepezza